Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.
British journal of cancer（2023）
摘要
ClinicalTrial.gov: NCT02660034.
更多查看译文
关键词
Cancer immunotherapy,Gastric cancer,Ovarian cancer,Prostate cancer,Small-cell lung cancer,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要